BOSTON--(BUSINESS WIRE)--Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's ...
Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's generative model for protein ...
Maybe you believe generative design and artificial intelligence (AI) are years away—nothing to think about. If so, you’re not alone. In Protolabs’ recently released report, Product Development Outlook ...